DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Harrison SA, Marri SR, Chalasani N. , et al.
Randomised clinical study: GR-MD-02, a galectin-3 inhibitor, vs. placebo in patients having non-alcoholic steatohepatitis with advanced fibrosis.
Aliment Pharmacol Ther 2016;
44 (11-12): 1183-1198
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.